{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:19:36Z","timestamp":1790741976376,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":2962,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.bbmt.2006.10.030","type":"journal-article","created":{"date-parts":[[2007,2,21]],"date-time":"2007-02-21T07:16:43Z","timestamp":1172042203000},"page":"345-354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Marrow Fibrosis as a Risk Factor for Posttransplantation Outcome in Patients with Advanced Myelodysplastic Syndrome or Acute Myeloid Leukemia with Multilineage Dysplasia"],"prefix":"10.1016","volume":"13","author":[{"given":"Bart L.","family":"Scott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry E.","family":"Storer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne E.","family":"Greene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Hackman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick R.","family":"Appelbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Joachim","family":"Deeg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2006.10.030_bib1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","article-title":"Proposals for the classification of the myelodysplastic syndromes","volume":"51","author":"Bennett","year":"1982","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2006.10.030_bib2","doi-asserted-by":"crossref","first-page":"620","DOI":"10.7326\/0003-4819-103-4-620","article-title":"Proposed revised criteria for the classification of acute myeloid leukemia","volume":"103","author":"Bennett","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2006.10.030_bib3","series-title":"World Health Organization Classification of Tumours","author":"Jaffe","year":"2001"},{"key":"10.1016\/j.bbmt.2006.10.030_bib4","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.10.030_bib5","doi-asserted-by":"crossref","first-page":"232a","DOI":"10.1182\/blood.V106.11.788.788","article-title":"A WHO classification-based prognostic scoring system (WPSS) for predicting survival in myelodysplastic syndromes","volume":"106","author":"Malcovati","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.10.030_bib6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF01698371","article-title":"Myelodysplastic syndromes with bone marrow fibrosis: a myelodysplastic disorder with proliferative features","volume":"63","author":"Verhoef","year":"1991","journal-title":"Ann Hematol"},{"key":"10.1016\/j.bbmt.2006.10.030_bib7","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1182\/blood-2002-09-2768","article-title":"Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hemopoietic stem cell transplantation","volume":"102","author":"Wells","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.10.030_bib8","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1182\/blood.V79.1.198.198","article-title":"Primary myelodysplastic syndromes: diagnostic and prognostic significance of immunohistochemical assessment of bone marrow biopsies","volume":"79","author":"Mangi","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.10.030_bib9","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0145-2126(01)00055-8","article-title":"Myelodysplasia with fibrosis: a distinct entity?","volume":"25","author":"Steensma","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.bbmt.2006.10.030_bib10","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1182\/blood.V65.6.1364.bloodjournal6561364","article-title":"Therapy-related acute myeloid leukemia and myelodysplastic syndrome: a clinical and morphologic study of 65 cases","volume":"65","author":"Michels","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.10.030_bib11","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-2141.1984.tb02916.x","article-title":"Bone marrow histology in myelodysplastic syndromes: I","volume":"57","author":"Tricot","year":"1984","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2006.10.030_bib12","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1365-2141.1995.tb05590.x","article-title":"The myelodysplastic syndromes: an analysis of prognostic factors in 226 cases from a single institution","volume":"90","author":"Cunningham","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2006.10.030_bib13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2141.1991.tb04411.x","article-title":"Myelodysplastic syndrome with increased marrow fibrosis: a distinct clinico-pathological entity","volume":"78","author":"Lambertenghi-Deliliers","year":"1991","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2006.10.030_bib14","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1600-0609.1992.tb01587.x","article-title":"Myelofibrosis in primary myelodysplastic syndromes: a retrospective study of 352 patients","volume":"48","author":"Maschek","year":"1992","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.bbmt.2006.10.030_bib15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF01695890","article-title":"Prognostic relevance of histological findings on bone marrow biopsy in myelodysplastic syndromes","volume":"66","author":"Lambertenghi-Deliliers","year":"1993","journal-title":"Ann Hematol"},{"key":"10.1016\/j.bbmt.2006.10.030_bib16","first-page":"141","article-title":"Myelodysplastic syndromes: a multiparametric study of prognostic factors and a proposed scoring system","volume":"75","author":"Cassano","year":"1990","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2006.10.030_bib17","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1053\/hupa.2003.58","article-title":"Evaluating the volume ratio of bone marrow affected by fibrosis: a parameter crucial for the prognostic significance of marrow fibrosis in chronic myeloid leukemia","volume":"34","author":"Buesche","year":"2003","journal-title":"Hum Pathol"},{"key":"10.1016\/j.bbmt.2006.10.030_bib18","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1038\/sj.leu.2403953","article-title":"Prognostic impact of vascular density and fibrosis in the bone marrow of children with high-risk acute lymphoblastic leukemia","volume":"19","author":"Noren-Nystrom","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2006.10.030_bib19","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1182\/blood-2004-01-0338","article-title":"A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome","volume":"104","author":"Cutler","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.10.030_bib20","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","article-title":"World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting, Airlie House, Virginia, November 1997","volume":"17","author":"Harris","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2006.10.030_bib21","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2141.1987.00369.x-i1","article-title":"Myelofibrosis: prognostic factors and treatment","volume":"69","author":"Manoharan","year":"1988","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2006.10.030_bib22","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2141.1979.tb03740.x","article-title":"The reticulin content of bone marrow in acute leukaemia in adults","volume":"43","author":"Manoharan","year":"1979","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2006.10.030_bib23","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1182\/blood-2002-02-0527","article-title":"Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome","volume":"100","author":"Deeg","year":"2002","journal-title":"Blood"},{"issue":"Part 1","key":"10.1016\/j.bbmt.2006.10.030_bib24","first-page":"213a","article-title":"Conditioning with fludarabine and targeted busulfan before transplantation of allogeneic hematopoietic stem cells","volume":"100","author":"Bornhauser","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.10.030_bib25","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1182\/blood.V82.2.677.677","article-title":"Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome","volume":"82","author":"Anderson","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.10.030_bib26","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1200\/JCO.1996.14.1.220","article-title":"Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factors","volume":"14","author":"Anderson","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2006.10.030_bib27","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1053\/bbmt.2002.v8.pm11939606","article-title":"Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome after conditioning with busulfan and fractionated total body irradiation is associated with low relapse rate but considerable nonrelapse mortality","volume":"8","author":"Jurado","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.10.030_bib28","series-title":"Thomas\u2019 Hematopoietic Cell Transplantation","first-page":"31","article-title":"Histocompatibility","author":"Mickelson","year":"2004"},{"key":"10.1016\/j.bbmt.2006.10.030_bib29","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1056\/NEJM198603203141201","article-title":"Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft-versus-host disease after marrow transplantation for leukemia","volume":"314","author":"Storb","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2006.10.030_bib30","first-page":"825","article-title":"1994 consensus conference on acute GVHD grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.10.030_bib31","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1182\/blood.V57.2.267.267","article-title":"Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression","volume":"57","author":"Sullivan","year":"1981","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.10.030_bib32","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/sj.bmt.1704767","article-title":"Serious graft-versus-host disease after hematopoietic cell transplantation following nonmyeloablative conditioning","volume":"35","author":"Flowers","year":"2005","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 1","key":"10.1016\/j.bbmt.2006.10.030_bib33","first-page":"105a","article-title":"Mycophenolate mofetil (MMF) as salvage treatment for graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT): safety analysis","volume":"90","author":"Nash","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.10.030_bib34","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1097\/00007890-200112270-00010","article-title":"Sirolimus (Rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease","volume":"72","author":"Benito","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2006.10.030_bib35","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1182\/blood.V99.8.2712","article-title":"A humanized non\u2013FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease","volume":"99","author":"Carpenter","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.10.030_bib36","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1182\/blood.V74.6.2220.2220","article-title":"Analysis of the origin of marrow cells in bone marrow transplant recipients using a Y chromosome\u2013specific in situ hybridization assay","volume":"74","author":"Durnam","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.10.030_bib37","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1182\/blood.V85.7.1954.bloodjournal8571954","article-title":"Quantitative determination of bone marrow transplant engraftment using fluorescent polymerase chain reaction primers for human identity markers","volume":"85","author":"Scharf","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.10.030_bib38","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1182\/blood.V77.7.1607.1607","article-title":"Amplification by the polymerase chain reaction of hypervariable regions of the human genome for evaluation of chimerism after bone marrow transplantation","volume":"77","author":"Ugozzoli","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.10.030_bib39","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1182\/blood.V95.4.1188.004k38_1188_1194","article-title":"Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age","volume":"95","author":"Deeg","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.10.030_bib40","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/jnci\/88.20.1483","article-title":"Prediction of relapse of pediatric acute myeloid leukemia by use of multidimensional flow cytometry","volume":"88","author":"Sievers","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bbmt.2006.10.030_bib41","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.bbmt.2006.10.030_bib42","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0197-2456(94)90003-5","article-title":"Simulation as a design tool for phase I\/II clinical trials: an example from bone marrow transplantation","volume":"15","author":"Gooley","year":"1994","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.bbmt.2006.10.030_bib43","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables (with discussion)","volume":"34","author":"Cox","year":"1972","journal-title":"J Royal Stat Soc B"},{"key":"10.1016\/j.bbmt.2006.10.030_bib44","first-page":"1997","article-title":"Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia","volume":"100","author":"Sierra","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.10.030_bib45","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1200\/JCO.2005.01.7038","article-title":"Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making","volume":"23","author":"Malcovati","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2006.10.030_bib46","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1182\/blood-2003-06-1856","article-title":"Allogeneic hematopoietic stem cell transplantation for myelofibrosis","volume":"102","author":"Deeg","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.10.030_bib47","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1182\/blood.V67.6.1693.1693","article-title":"Adverse effect of severe marrow fibrosis on hematological recovery after chemoradiotherapy and allogeneic bone marrow transplantation","volume":"67","author":"Rajantie","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.10.030_bib48","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1182\/blood.V86.12.4667.bloodjournal86124667","article-title":"Relevance of marrow fibrosis in bone marrow transplantation: a retrospective analysis of engraftment","volume":"86","author":"Soll","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.10.030_bib49","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMoa041668","article-title":"Efficacy of lenalidomide in myelodysplastic syndromes","volume":"352","author":"List","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2006.10.030_bib50","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1200\/JCO.2002.04.117","article-title":"Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B","volume":"20","author":"Silverman","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2006.10.030_bib51","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1182\/blood.V51.2.189.189","article-title":"Agnogenic myeloid metaplasia: a clonal proliferation of hematopoietic stem cells with secondary myelofibrosis","volume":"51","author":"Jacobson","year":"1978","journal-title":"Blood"},{"issue":"Part 1","key":"10.1016\/j.bbmt.2006.10.030_bib52","first-page":"353a","article-title":"Marrow stromal cells are not derived from the malignant clone in myelodysplastic syndromes (MDS)","volume":"98","author":"Awaya","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.10.030_bib53","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1182\/blood.V75.7.1540.1540","article-title":"The production of transforming growth factor-beta in acute megakaryoblastic leukemia and its possible implications in myelofibrosis","volume":"75","author":"Terui","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.10.030_bib54","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1046\/j.1365-2141.1997.4843288.x","article-title":"The role of transforming growth factor-beta in PEG-rHuMGDF\u2013induced reversible myelofibrosis in rats","volume":"99","author":"Yanagida","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2006.10.030_bib55","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1365-2141.1997.292671.x","article-title":"Elevated levels of basic fibroblast growth factor in megakaryocytes and platelets from patients with idiopathic myelofibrosis","volume":"97","author":"Martyre","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2006.10.030_bib56","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1365-2141.1989.tb04310.x","article-title":"Transforming growth factor-beta regulates growth as well as collagen and fibronectin synthesis of human marrow fibroblasts","volume":"72","author":"Kimura","year":"1989","journal-title":"Br J Haematol"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879106007518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879106007518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:29:39Z","timestamp":1761056979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879106007518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S1083879106007518"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2006.10.030","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Marrow Fibrosis as a Risk Factor for Posttransplantation Outcome in Patients with Advanced Myelodysplastic Syndrome or Acute Myeloid Leukemia with Multilineage Dysplasia","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2006.10.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}